Segall Bryant & Hamill LLC purchased a new position in shares of The Procter & Gamble Company (NYSE:PG - Free Report) in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 30,314 shares of the company's stock, valued at approximately $5,250,000.
Several other hedge funds have also recently modified their holdings of PG. Prospera Private Wealth LLC increased its position in Procter & Gamble by 240.7% during the 3rd quarter. Prospera Private Wealth LLC now owns 10,589 shares of the company's stock worth $1,834,000 after purchasing an additional 7,481 shares during the period. Counterweight Ventures LLC acquired a new position in Procter & Gamble during the third quarter worth $251,000. West Family Investments Inc. raised its position in Procter & Gamble by 15.6% in the third quarter. West Family Investments Inc. now owns 11,743 shares of the company's stock worth $2,034,000 after acquiring an additional 1,586 shares in the last quarter. B. Metzler seel. Sohn & Co. Holding AG acquired a new stake in Procter & Gamble in the third quarter valued at $301,950,000. Finally, SouthState Corp grew its stake in shares of Procter & Gamble by 0.4% during the 3rd quarter. SouthState Corp now owns 78,995 shares of the company's stock worth $13,682,000 after purchasing an additional 289 shares during the period. 65.77% of the stock is owned by institutional investors and hedge funds.
Analyst Ratings Changes
A number of research firms recently commented on PG. Hsbc Global Res upgraded shares of Procter & Gamble to a "strong-buy" rating in a research report on Friday, October 4th. Barclays cut Procter & Gamble from an "overweight" rating to an "equal weight" rating and set a $163.00 price objective for the company. in a report on Monday, September 30th. DA Davidson reissued a "neutral" rating and issued a $160.00 target price on shares of Procter & Gamble in a report on Wednesday. DZ Bank raised Procter & Gamble from a "hold" rating to a "buy" rating and set a $190.00 price target for the company in a research note on Thursday, August 29th. Finally, Morgan Stanley increased their price objective on shares of Procter & Gamble from $174.00 to $191.00 and gave the company an "overweight" rating in a research note on Monday, October 21st. Nine equities research analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat, Procter & Gamble presently has a consensus rating of "Moderate Buy" and an average target price of $178.00.
Get Our Latest Report on PG
Insider Transactions at Procter & Gamble
In other Procter & Gamble news, insider Balaji Purushothaman sold 12,800 shares of the firm's stock in a transaction dated Thursday, October 24th. The stock was sold at an average price of $168.99, for a total value of $2,163,072.00. Following the transaction, the insider now directly owns 11,566 shares of the company's stock, valued at $1,954,538.34. This trade represents a 52.53 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Susan Street Whaley sold 634 shares of the company's stock in a transaction dated Wednesday, October 2nd. The stock was sold at an average price of $171.65, for a total value of $108,826.10. Following the completion of the sale, the insider now directly owns 19,341 shares of the company's stock, valued at $3,319,882.65. The trade was a 3.17 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 160,693 shares of company stock worth $27,311,345 in the last three months. 0.18% of the stock is currently owned by company insiders.
Procter & Gamble Trading Up 2.0 %
Shares of NYSE PG traded up $3.53 on Friday, reaching $176.28. 10,609,785 shares of the company traded hands, compared to its average volume of 6,613,133. The company has a 50 day moving average of $170.04 and a 200 day moving average of $168.64. The company has a current ratio of 0.75, a quick ratio of 0.55 and a debt-to-equity ratio of 0.50. The Procter & Gamble Company has a fifty-two week low of $142.50 and a fifty-two week high of $177.94. The stock has a market capitalization of $415.15 billion, a PE ratio of 30.39, a P/E/G ratio of 3.74 and a beta of 0.42.
Procter & Gamble (NYSE:PG - Get Free Report) last announced its quarterly earnings results on Friday, October 18th. The company reported $1.93 earnings per share for the quarter, beating analysts' consensus estimates of $1.90 by $0.03. The company had revenue of $21.74 billion for the quarter, compared to analyst estimates of $21.99 billion. Procter & Gamble had a net margin of 17.07% and a return on equity of 33.25%. Procter & Gamble's revenue for the quarter was down .6% on a year-over-year basis. During the same quarter last year, the business earned $1.83 EPS. On average, equities research analysts forecast that The Procter & Gamble Company will post 6.94 earnings per share for the current fiscal year.
Procter & Gamble Announces Dividend
The company also recently declared a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Friday, October 18th were paid a dividend of $1.0065 per share. The ex-dividend date was Friday, October 18th. This represents a $4.03 annualized dividend and a yield of 2.28%. Procter & Gamble's dividend payout ratio is presently 69.48%.
About Procter & Gamble
(
Free Report)
The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.
Featured Articles
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio.
Get This Free Report